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OBJECTI ˙VE: The goal of the study was to investigate the regıonal ıntravenous anesthesıa procedure in knee
arthroscopy and to evaluate the effects of adding ketamine over the anesthesia block charactery and tourniquet
pain.
MATERI ˙AL/METHOD: Forty American Society of Anesthesiologists (ASA) II patients who received knee arthroscopy
were enrolled. After monitoring, a peripheral IV line was inserted.The venous blood in the lower extremity was
evacuated with a bandage, and the proximal cuff of the double-cuff tourniquet was inflated. The patients were
randomly split into two groups. While Group P received 80 ml 0.5% prilocaine, Group PK received 0.15 mg/kg
ketamine (80 ml in total) via the dorsum of the foot. We recorded onset time of the sensory block, end time of the
sensory block, presence of the motor block, the time when the patient verbally reported tourniquet pain and
surgical pain, duration of tourniquet tolerance, fentanyl consumption during the operation, time to first analgesic
requirement, methemoglobin values at 60 minutes, operative conditions, 24-hour analgesic consumption, discharge
time, and hemodynamic parameters.
RESULTS: The body mass index (BMI) of the patients who required general anesthesia was significantly higher than
the BMI of other patients. The onset time of the sensory block was shorter for those in Group PK, but the time to
first analgesic requirement was longer.
CONCLUSI ˙ON: Regıonal ıntravenous anesthesıa using the doses and volumes commonly used in knee arthroscopy
may be an inadequate block among patients with high BMI values. Moreover, the addition of ketamine to the local
anesthetic solution may produce a partial solution by shortening the onset of sensory block and prolonging the
time until the first analgesic is required.
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Regional intravenous anesthesia (RIVA) was first
described by Bier in 1908 and gained popularity following
modifications made by Holmes in 1963.
1 The most impor-
tant advantages of using the technique are that it’s
easy-to-apply, reliable, and cost-effective.
2 It has gained
wide popularity in upper extremity surgery due to its
reported success rates of between 94-98%.
Knee arthroscopy is one of the most commonly performed
orthopedic procedures. Various anesthesia methods have
been successfully used in this procedure, such as local
anesthesia, peripheral-neuroaxial blocks, and general
anesthesia. Nonetheless, experts continue to debate which
anesthesia method would increase patient satisfaction, best
fit surgical conditions, and allow the most effective usage of
the operating room.
4,5
Although RIVA has been used in many surgeries
involving the lower extremities, except for one case report,
there has been no study of using it in knee arthroscopy.
6
In the current study, we aimed to determine whether
RIVA could be effective in knee arthroscopy and to evaluate
the effects of adding ketamine to the regimen over block
charactery and tourniquet pain.
MATERIALS AND METHODS
Following the approval of the Ministery of Healt Ankara
Numune Training and Research Hospital ethics committee,
40 patients (19-65 years old) with ASA 1-2 physical status
who signed an informed consent form were included in the
current study. Patients with the following conditions were
excluded from the study: Reynaud disease; sickle cell
anemia; peripheral neuropathy or central nervous system
disorder; deep vein thrombosis, infection, skin problems, or
active arthritis in the related extremity; uncontrolled
hypertension; and presence or history of allergic reaction
to prilocaine or ketamine. The patients who required
general anesthesia due to tourniquet pain or surgical pain
were recorded and also excluded from the study.
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831After the patients were inside the operating room, we
measured their heart rate, noninvasive blood pressure, and
respiratory rate. Their O2 saturation was analyzed using
pulse oximetry, and the ECG (PM 8060 Vitara, Germany)
was examined. Following the insertion of a peripheral IV
line in the dorsum of the foot, all the patients were
premedicated with intravenous 0.04 mg/kg midazolam.
Then we placed a double-cuff tourniquet (8) (VBM,
Medizintechnik GmbH 30 inch/76 cm) above knee. The
patients were randomly split into two groups. Group P
received 0.5% prilocaine (80 mL), and Group PK received
0.5% prilocaine + 0.15 mg/kg ketamine (80 mL in total).
The prepared solutions were delivered from the dorsum
of the foot in 90 seconds. A sensory block was started and
was evaluated five minutes following the drug delivery, and
the examination was repeated once a minute using a
pinprick test. The patient was instructed to move his or
her big toe at one-minute intervals to assess the motor block.
Onset time of sensory block was defined as the time that
passed until the development of a sensory block in all the
dermatome levels tourniquet.
End time of sensory block: Development of sensory block
after the release of the tourniquet was evaluated each
minute using the pinprick method.
Motor block evaluation: Failure to flex the big toe indicated
the presence of a motor block.
Assessment of the tourniquet pain was done using VAS
(verbal pain scale) at 0, 10, 20, 30, 40, 50, and 60 minutes,
beginning with the inflation of the distal cuff (Table 1).
Surgical pain was evaluated following the incision by VAS
at 0, 10, 20, 30, 40, 50, and 60 minutes.
Duration of tourniquet tolerance was the length of time
between distal cuff inflation and time when patient asked
for analgesic.
Perioperative analgesic consumption: As additional analgesic
was needed due to tourniquet pain or surgical pain, 50 mg
fentanyl iv bolus delivery was performed (maximum
3 mg/kg). The amounts consumed for tourniquet pain and
surgical pain were recorded separately.
Perioperative period: Average arterial pressure, heart rate,
and SpO2 were recorded before and after the tourniquet
placement, at the moment when the distal cuff was inflated
and when the proximal cuff was deflated, during the
surgical incision and first 30 minutes at 5-minute intervals
following the incision, and at 15-minute intervals during the
ensuing period.
Postoperative period: One and five minutes following the
release of the tourniquets, values for heart rate, blood
pressure, and SpO2 were recorded.
The interval between the inflation and deflation of the
first tourniquet was recorded as the tourniquet duration.
The interval between the tourniquets’ deflation and time to
first analgesic requirement was recorded as the time to first
analgesic requirement. As needed, patients were delivered a
75 mg oral diclofenac tablet as an analgesic, and the
analgesic consumption within the first 24 hours was noted.
Operative conditions were graded by the surgeon after the
end of the operation as 0: unsuccessful, 1: poor, 2:
acceptable, and 3: perfect.
The patients were evaluated in terms of numbness of the
tongue or around the mouth, dizziness, tinnitus, drowsi-
ness, tremor, convulsions, and toxicity signs, such as
arrhythmia and cyanosis, as well as psychomimetic side
effects associated with ketamine, such as hypertension,
tachycardia, euphoria, hallucinations, confusion, and delir-
ium. Sixty minutes after the end of the operation, we
measured methemoglobin levels of the patients.
Statistical Analysis
The data were analyzed using the SPSS 12 software
program. We investigated the distribution of variables
(normal or not) obtained on the basis of equal intervals
and ratio scale. The Kolmogorov-Smirnov concordance test
and the low number of subjects alongside an examination of
the histograms by calculating the kurtosis and skewness
indicated that the distribution was not normal. The analysis
was conducted using the chi-square test of categorical data
and the Mann-Whitney U test of the variables with
abnormal distribution that were collected on the basis of
the ratio. P,0.05 was recognized as statistically significant.
RESULTS
There was no statistically significant difference between
the groups with regard to age, weight, gender, ASA
physical status scores, operation length, and tourniquet
duration (Table 2).
We had to switch to general anesthesia for 5 patients in
Group P and 6 patients in group PK.
The onset time for using the sensory block was
significantly shorter in the PK group. There was no
statistically significant difference between the groups in
terms of the end time of sensory block usage, motor block
percentages, and duration of tourniquet tolerance (Table 3).






5 Very severe pain
Table 2 - Demographic data, tourniquet duration, and
operation length (median value, minimum-maximum).
P PK P value
Age (year) 45 (19-65) 42.5 (19-58) 0.291
Weight (kg) 80 (58-87) 76.5 (57-95) 0.870
Height (cm) 165,5(155-185) 170 (152-185) 0.472
Gender F/M 9/11 8/12 0.749
ASA I/II 5/15 11/9 0.078
Tourniquet duration (min.) 50 (45-69) 49 (14-83) 0.646
Operation lelength (min.) 32 (21-48) 35 (19-69) 0.694
Table 3 - Onset time of sensory block (OTSB), end time of
sensory block (ETSB), presence of motor block (MB),
duration of tourniquet tolerance (DTT) (median value,
minimum-maximum).
GROUP P GROUP PK P value
OTSB (min.) 14 (9-19) 10.50 (7-18) 0.047
ETSB (min.) 8 (5-18) 10 (5-15) 0.323
MB 20% 21.4% ,0.999
DTT (min.) 18 (2-55) 25 (6-41) 0.793
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832The tourniquet pain value at 0 minutes was significantly
high in the P group (Table 4). VAS values for surgical pain
were significantly high at 10 and 30 minutes (Table 5).
Between the groups, there was no significant difference
with regard to fentanyl consumption for tourniquet pain,
fentanyl consumption for surgical pain, and operative
conditions (Table 6).
While time to first analgesic requirement was signifi-
cantly longer in the Group PK, there was no significant
difference between the groups in terms of 24-hour analgesic
consumption (Table 7). No significant difference was
determined with regard to discharge time and methemo-
globin values at 60 minutes (Table 8).
There was no significant difference between the groups in
terms of the heart rate (HR) (Figure 1), mean arterial
pressure (Figure 4), and oxygen saturation.
After the release of the tourniquet, we observed perioral
numbness in 4 patients in Group P and 3 patients in Group
PK, tinnutus in one patient in each group, euphoria in one
patient in Group PK, tremor in 3 patients in Group PK and
one patient in Group P, and dizziness in 3 patients in Group
PK. Side effects required no intervention. There were no
differences between the groups in terms of side effects.
DISCUSSION
In the current study, onset time of sensory block was
shorter (10.5 minutes – 14 minutes, p=0.047), tourniquet
pain at 0 minutes (baseline) and surgical pain at 10 and
30 minutes were lower, and time to first analgesic
requirement was longer (177.5 minutes – 468.5 minutes,
p=0.002) in Group PK. Six patients (30%) in group PK
required a switch to general anesthesia.
There are few studies in the literature on using the RIVA
procedure in lower-extremity surgery. Lehman and Jones
applied the RIVA method to 54 patients for procedures
involving the knee and its distal parts by delivering 3.3
mg/kg 0.25% lidocaine
7 and switched to another method
for cases in which patients failed to achieve anesthesia
within 15 minutes. Their success rate with this method was
94%. Davies applied RIVA by delivering 3 mg/kg 0.5%
Table 4 - VAS values for tourniquet pain (TPVAS) (median,
minimum-maximum).
GROUP P GROUP PK P value
TPVAS0 2 (1-4) 1 (1-3) 0.036
TPVAS10 2 (1-4) 1,5 (1-4) 0.175
TPVAS20 2 (1-4) 3 (1-4) 0.385
TPVAS30 2 (1-4) 2,5 (1-4) 0.698
TAVAS40 3 (1-4) 3 (1-4) 0.885
TAVAS50 3,5 (2-4) 4 (2-5) 0.536
Table 8 - Discharge time (DS) and methomoglobin values
at 60 minutes (metHb) (median value, minimum-
maximum).
MetHb(%) 3.1(1.1-6.1) 3.95(2.7-7.8) 0.101
DS(hour) 23(20-25) 23.5(20-26) 0.841
Table 7 - Time to first analgesic requirement, 24-hour
analgesic consumption (median value, minimum-
maximum).
GROUP P GROUP PK P value
I ˙AGZ(dk) 177.5(97-577) 468.50(192-1028) 0.002
24 AT(mg) 150(0-150) 75(75-150) 0.298
Table 6 - Fentanyl consumption for tourniquet pain
(FCTP), fentanyl consumption for surgical pain (FCSP), and
operative conditions (OC) (median value, minimum-
maximum).
GROUP P GROUP PK P value
TAFT(mg) 150(0-250) 100(0-200) 0.859
CAFT(mg) 0(0-50) 0(0-250) 0.354
OK 2(1-3) 3(2-3) 0.080
Table 5 - Surgical pain VAS values (SPVAS) (median,
minimum-maximum).
GROUP P GROUP PK P value
SPVAS0 1 (1-3) 1 (1-3) 0.620
SPVAS10 2 (1-2) 1 (1-1) 0.041
SPVAS20 1 (1-4) 1 (1-2) 0.354
SPVAS30 2 (1-4) 1 (1-1) 0.044
Figure 1 - Variation of heart rates relative to time.
HRBT: Heart Rate Before tourniquet, HRAT: After tourniquet, HRIDC: Inflation of the distal cuff, HRSI: Surgical incision, HRRT1: First
minute after the release of the tourniquet, HRRT5: Fifth minute after the release of the tourniquet
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833prilocaine to 48 patients undergoing foot surgery; he
achieved adequate analgesia in 44 patients and sedation in
1 patient, and additional local anesthetic infiltration was
required in 3 patients.
8 Nusbaum and Hamelberg per-
formed RIVA by using calf tourniquets and delivering 30-
40 ml 0.5% lidocaine to 40 patients undergoing foot and
ankle surgery and achieved a successful block in 39
patients.
9 Kim et al. placed a tourniquet at the ankle level,
used 35 mL 0.33% or 0.5% lidocaine, and succeeded with 31
(79.5%) of 39 patients.
10 Schurg et al. used 200 mg prilocaine
during foot surgery on 17 patients, administered an
additional 100 mg prilocaine when adequate analgesia
was not achieved within 5 minutes, and succeeded with
15 patients.
11 Our success rate of 72.5% was similar to that
experienced by Kim et al.
In the present study, we had to switch to general
anesthesia in 5 (25%) patients in Group P and 6 (30%)
patients in Group PK. The underlying causes for the switch
to general anesthesia in Group P were unsuccessful block in
2 patients, incisional pain in one patient, and tourniquet
pain in one patient. Among the patients in Group PK, we
switched to general anesthesia due to tourniquet pain in 5
patients and incisional pain in 1 patient. The BMIs of
patients who were switched to general anesthesia were
significantly higher than others (median values: 29.3 – 25.1,
p= 0,035). We believe that this difference reduces the
success rate of the block because it enlarges the area that
will receive the solution and makes complete evacuation of
the extremity difficult by complicating the application of the
Esmarch bandage. The underlying reason for switching to
general anesthesia was tourniquet pain in 7 (63%) of 11
patients. We believe that the high number of muscles in the
femoral region and the various positions assumed by the
knee during arthroscopy may increase the tourniquet pain.
Lehman and Jones used a femoral tourniquet in their
studies and gained a higher success rate than we did. Their
patients who were subjected to RIVA presented with minor
orthopedic complaints, such as closed reduction, debride-
ment, foreign body removal, and tendon repair. None-
theless, the anesthetic volume they used was higher. We
think the difference in the success rates may be due to those
two reasons.
In light of their 20-year experience, Brown et al. stated
that the injection of 150 mL local anesthetic solution should
be required in RIVA with femoral tourniquet.
4 AL-Metwalli
and Mowafi applied RIVA successfully with 40 mL 0.5%
lidocaine by using the ‘‘modified inter-cuff’’ technique that
they described in a case report they published in 2002.
6 We
took those two studies into consideration and decided to use
an 80 mL solution, following the technique of Al-Metwalli
and Mowafi. Our results suggest that while applying RIVA
with a femoral tourniquet, the volume to be used should be
determined according to the BMIs of the patients.
In the present study, among the ketamine group, onset
time of sensory block was significantly shorter and the time
to the first analgesic requirement was longer. Moreover,
tourniquet pain at 0 minutes as well as surgical pain at 10
and 30 minutes were significantly lower in the ketamine
group. While only 2 patients in the ketamine group required
additional analgesic due to pain in the surgical area (100 mg
fentanyl in total), 4 patients in the other group required
additional anesthetic (450 mg fentanyl in total).
The local anesthetic effect of ketamine was first shown by
Dowdy et al. who experimented on laboratory animals
in 1973.
12 Following this result, Amiot et al. applied RIVA
during upper-extremity surgery and delivered a 40 mL 0.5%
ketamine solution to 14 patients, and they succeeded in
establishing complete sensory block within an average time
of 14 minutes.
13 While the operation was completed with
this technique in 12 patients, the average time for complete
motor block was 17.3 minutes in 9 patients, and 4 patients
received 5 mg iv diazepam due to failure to tolerate a
tourniquet. Following the release of the tourniquet, all the
patients demonstrated unconsciousness for 10 minutes, but
no sequelae ensued. Durrani et al. administered 0.6 mL/kg
ketamine in 0.5%, 0.3%, and 0.2% concentrations along with
RIVA in order to investigate whether ketamine could
provide adequate surgical anesthesia without inducing
unconsciousness following the release of the tourniquet.
14
While 0.2% f the group was excluded from the study
because of unbearable tourniquet pain, they succeeded in
establishing complete sympathetic, sensory, and motor
block in the other two groups. Even after the release of
the tourniquet, hemodynamic signs showed no marked
difference. All the volunteers demonstrated loss of sense of
reality and/or hallucinations, but none of them exhibited
loss of consciousness. Although normal orientation was
achieved in all the volunteers within 20 minutes by
administering intravenous diazepam, patients defined this
experience as unacceptable and unpleasant.
Researchers who completed anatomical studies reported
the presence of NMDA receptors in unmyelinated sensory
Figure 2 - Variation of average blood pressures relative to time.
APBT: Average blood pressure Before tourniquet, APAT: After tourniquet, APIDC: Inflation of the distal cuff, APSI: Surgical incision,
APRT1: First minute after the release of the tourniquet, APRT5: Fifth minute after the release of the tourniquet.
Rıva in Knee
Arslan M et al.
CLINICS 2010;65(9):831-835
834axons.
15 The blockage of those receptors may be responsible
for the peripheral analgesic effect of ketamine. Frenkel and
Urban showed that ketamine blocked human Na
+ channels
when delivered at higher concentrations than in general
anesthesia.
16 This result was consistent with the findings of
Durrani et al. Tverovsky et al. reported that ketamine
increased the anesthetic and analgesic effects of bupivacaine
in infiltration anesthesia through a peripheral mechanism.
17
Since we cannot expect achieving a local anesthesia with a
0.15 mg/kg direct dose of ketamine, we believe that the
positive effects obtained in our study were associated with
the interaction of ketamine and prilocaine as reported in the
studies of Tverovsky et al. Gorgias et al. conducted the only
study in which local anesthetic and ketamine were
delivered together and reported that the addition of
0.1 mg/kg ketamine to the lidocaine delayed the tourniquet
pain and reduced the analgesic consumption for tourniquet
pain.
Because there was no data on the onset time of the
sensory block and time to the first analgesic requirement,
we cannot compare the results with those of our study. One
of the most important reasons that doctors rarely use RIVA
is that side effects may arise because it requires a high-dose
of local anesthetic. The most feared side effect of that local
anesthetic is methemoglobinemia. Prilocaine metabolites, 2-
hydroxy, 2 methylaniline, and 2-methylaniline, oxidize
normal hemoglobin and lead to methemoglobinemia. If a
patient experiences clinical cyanosis and is unresponsive to
100% oxygen therapy, the healthcare professional should
suspect methemoglobinemia. In healthy individuals, clinical
symptoms such as dyspnea, nausea, and tachycardia occur
when the methemoglobin level rises above 30%. When the
methemoglobin level reaches 55%, conciousness is affected,
whereas a level of 70% is generally fatal. Some authors
stated that no treatment should be applied if methemoglo-
bin levels are below 30% among patients with no cardio-
pulmonary problems.
18 In the current study, we used
400 mg prilocaine for anesthesia in arthroscopic surgery.
In their study comparing the use of lidocaine and
prilocaine for RIVA, Bader et al. determined that the highest
methemoglobin levels occurred 60 minutes after the release
of the tourniquet. Therefore, we evaluated methemoglobin
levels at 60 minutes. The highest methemoglobin level we
determined was 7.8%. None of the patients in our study
displayed cyanosis or dyspnea. We observed perioral
numbness in 3 patients and tinnitus in 2 patients. Thus,
we believe that the dose and volume we used in the current
study are safe.
Using the RIVA procedure for knee arthroscopy with the
dose and volumes used in the current study may not
achieve an adequate block, particularly in patients with high
BMIs. We believe that determining the volume and doses
required for the RIVA method, particularly in surgical
procedures where a femoral tourniquet is needed in the
lower extremity, will elevate the success rate. Nonetheless,
the addition of ketamine to the local anesthetic solution may
partially contribute to the block quality by shortening the
onset of the sensory block and delaying the time when the
first analgesic is required.
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